Drugs / IPL512,602
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00330070 | May 2006 → Jan 2007 | asthma | Inflazyme Pharmaceuticals Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPL512,602 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00330070 ↗ |
| Route | Oral | “Oral IPL512,602” NCT00330070 ↗ |